Trade Names: | |
Synonyms: | |
Status: | Approved (1993) |
Entry Type: | Oligosaccharide |
Molecule Category: | Salt |
UNII: | 8NZ41MIK1O |
Parent Compound: | ENOXAPARIN |
Action | Mechanism of Action | Reference |
---|---|---|
ACTIVATOR | Antithrombin-III activator | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Venous Thrombosis | 4 | D020246 | ClinicalTrials |
Thrombosis | 4 | D013927 | ClinicalTrials |
Pulmonary Embolism | 4 | D011655 | ClinicalTrials |
Myocardial Infarction | 4 | D009203 | ClinicalTrials |
Genital Neoplasms, Female | 3 | D005833 | ClinicalTrials |
Obesity | 3 | D009765 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Liver Cirrhosis | 3 | D008103 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Infections | 3 | D007239 | ClinicalTrials |
Small Cell Lung Carcinoma | 3 | D055752 | ClinicalTrials |
Kidney Diseases | 3 | D007674 | ClinicalTrials |
Hip Fractures | 3 | D006620 | ClinicalTrials |
ST Elevation Myocardial Infarction | 3 | D000072657 | ClinicalTrials |
Myocardial Ischemia | 3 | D017202 | ClinicalTrials |
Thromboembolism | 3 | D013923 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Venous Thromboembolism | 3 | D054556 | ClinicalTrials |
Fetal Growth Retardation | 3 | D005317 | ClinicalTrials |
Abortion, Habitual | 3 | D000026 | ClinicalTrials |
Atrial Fibrillation | 3 | D001281 | ClinicalTrials |
Stroke | 2 | D020521 | ClinicalTrials |
Staphylococcal Infections | 2 | D013203 | ClinicalTrials |
Blood Coagulation Disorders | 2 | D001778 | ClinicalTrials |
Nephrotic Syndrome | 2 | D009404 | ClinicalTrials |
Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Hemorrhage | 1 | D006470 | ClinicalTrials |
Acute Coronary Syndrome | 1 | D054058 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL1201476 |
FDA SRS | 8NZ41MIK1O |
PubChem | 772 |